Skip to content

Serum Endocan Levels and Gestational Diabetes

Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05237895
Enrollment
90
Registered
2022-02-14
Start date
2022-03-03
Completion date
2022-05-05
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocan, Gestational Diabetes

Brief summary

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Detailed description

It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregnancy. From the information obtained from these studies, it can be said that there is a strong association between diabetes mellitus and serum endocan levels. investigators aimed to determine the relationship between serum endocan levels and gestational diabetes in the study.

Interventions

DIAGNOSTIC_TESTSerum Endocan Levels

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* being pregnant at 24-26 weeks of gestation * having oral glucose toleranse screening test * age between 18-45 years

Exclusion criteria

* having in utero mort fetus * having a previous diagnosis of diabetes * having a multiple pregnancy * having a coronary artery disease * having preeclampcia * having a pregnancy obtained by assisted reproductive technology * using cigarette * using alcohol

Design outcomes

Primary

MeasureTime frameDescription
Detection of diagnostic value of serum endocan levels in patient with gestational diabetes3 monthsIdentifying diagnostic value of serum endocan by comparing serum levels of endocan in groups.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026